30 January 2008
Rapid progression of Wegener’s Granulomatosis to therapy related Myelodysplastic Syndrome and Acute Myelomonocytic Leukemia: case report
Christos Bomboris, George Andreopoulos, Nora-Athina Viniou, Stefanos Koyndoyris, Nikolaos Kaklamanis, Maria Moschogianni, John Dalamagas, Eleni Variami, Anastasios Andreopoulos, George Vaiopoulos, John Meletis, Gerasimos PangalisAm J Case Rep 2008; 9:74-77 :: ID: 744378
Abstract
Background: Treatment of Wegener’s Granulomatosis (WG) with Cyclophosphamide still remains a problem for developing secondary malignancies.
Case Report: A 64 year old patient diagnosed with WG in May 2004, developed RAEB I MDS and Acute Myelomonocytic Leukemia after treatment with relatively low dose of Cyclophosphamide 26 months after diagnosis of rheumatic disease.
Conclusions: We suggest close hematological monitoring of WG patients treated with alkylating agents for early diagnosis of secondary, therapy related, disorders.
Keywords: Wegener’s granulomatosis, Alkylating Agents, myelodysplastic syndrome
In Press
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.949194
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.948731
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.947386
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.948268
Most Viewed Current Articles
21 Jun 2024 : Case report
101,937
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
07 Mar 2024 : Case report
54,506
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133
20 Nov 2023 : Case report
38,182
DOI :10.12659/AJCR.941424
Am J Case Rep 2023; 24:e941424
07 Jul 2023 : Case report
25,994
DOI :10.12659/AJCR.940200
Am J Case Rep 2023; 24:e940200